The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hanskumar Shamji Shah & Others
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 0.3 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Hemant Surgical Industries' promoters — Hanskumar Shamji Shah, Hemant Praful Shah, and Kaushik Hanskumar Shah — were allotted 6,00,000 warrants (2,00,000 each) via preferential allotment on September 16, 2025. Each warrant is convertible into one equity share of Rs. 10 within 18 months. Before this, the promoter group held 73.56% of voting capital (50.74% on a fully diluted basis). After including the warrants, their diluted holding rises to 54.19%. The company's equity capital will increase from Rs. 10.44 crore (1.04 crore shares) to Rs. 13.04 crore (1.30 crore shares) on full conversion, and total diluted capital will stand at Rs. 15.14 crore (1.51 crore shares) once all warrants are converted. The disclosure was filed under SEBI Takeover Regulations and signed on September 22, 2025.
This signals promoter confidence in the company as insiders are putting in additional capital via warrants rather than selling. The preferential route also dilutes existing non-promoter shareholders by about 25% on equity base, though promoter control strengthens further on a diluted basis. Short-term stock reaction may be muted as warrants come with an 18-month conversion window and a future exercise price, but it reinforces promoter commitment.